期刊文献+

组织多普勒超声评价窄QRS间期患者心脏再同步治疗效果 被引量:2

Efficacy research of cardiac resynchronization therapy in heart failure with narrow QRS complexes
原文传递
导出
摘要 目的组织多普勒超声(TDI)指导下评价窄QRS间期合并心室不同步患者行心脏再同步治疗(CRT)对临床预后的影响。方法91例经超声心动图和TD[确诊为心脏收缩不同步的慢件心力衰竭患者,按是否接受CRT分为CRT组(窄QRS间期21例,宽QRS间期22例)和对照组(宽QRS间期25例,窄QRS间期23例)。对所有患者进行1年的随访,评价心功能及生存率。结果CRT组6min步行试验、生活质量积分、心功能(NYHA分级)明显改善。超声心动图及TDI结果显示,CRT组左心室收缩未容积、左心室舒张末容积明显减少,射血分数明显增加。与各对照组亚组相比,CRT组中窄QRS亚组心功能改善,6min步行试验距离、左心室射血分数、生活质量积分明垃增加,左心室收缩末容积和左心窀舒张末容积明显减少。结论在TDI指导下,窄QRS间期慢性心力衰竭可以从CRT中获益。 Objective To evaluate the effects of cardiac resynchronization therapy (CRT) in congestive heart failure (CHF) patients presenting with left ventricular mechanical asynchrony and analyze wether CHF patients with narrow QRS complexes benefit from CRT. Methods We enrolled 91 patients who had an indication for CRT with conventional echoeardiographic technique and tissue doppler imaging (TDI). Patients were assigned to the CRT group(narrow QRS group 21 patients,wide QRS group 22 patients) and to a control group (narrow QRS group 23 patients ,wide QRS group :25 patients). We evaluated cardiac function,and survival rates at one year follow-up. Results In the CRT group at one year,there was a significant improvement over con- trols on 6-min walking test,quality-of-life score,and NYHA functional class,as well as a significant reduction in left ventricular (LV) end-systolic volume and LV end-diastolic volume. Further analysis showed similar improvement in CRT- narrow QRS complexes subgroup. Conclusion CRT can improve heart function and increase quality of life in patients with moderate-to-severe CHF, narrow QRS complexes CHF patients also benefit from CRT.
出处 《中华心律失常学杂志》 2009年第2期137-140,共4页 Chinese Journal of Cardiac Arrhythmias
基金 辽宁省自然科学基金(20082073)
关键词 心脏再同步治疗 窄QRS间期 组织多普勒 Cardiac resynchronization therapy Narrow QRS complexes Tissues doppler
  • 相关文献

参考文献15

  • 1Young JB,Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA, 2003,289 : 2685-2694.
  • 2Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med, 2002,346:1845-1853.
  • 3华伟,王方正,张澍,牛红霞,陈柯萍,陈新.心脏再同步治疗缺血性与非缺血性心肌病的临床应用[J].中华心律失常学杂志,2005,9(6):405-408. 被引量:22
  • 4王冬梅,韩雅玲,臧红云,荆全民,王祖禄,王守力,李菲.心脏再同步治疗慢性心力衰竭的植入术并发症及术后病死率分析[J].中华心律失常学杂志,2006,10(2):113-116. 被引量:6
  • 5Bleeker GB, Schalij MJ, Molhoek SG, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol,2004,15 : 544- 549.
  • 6Ghio S, Constantin C, Klersy C, et al. Interventricular and intraventricular dyssynehrony are common in heart failure patients, regardless of QRS duration. Eur Heart J ,2004,25:571-578.
  • 7Achilli A, Sassara M, Ficili S, et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and " narrow" QRS. J Am Coil Cardiol, 2003,42 : 2117- 2124.
  • 8Yu CM,Chan YS, Zhang Q, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol, 2006,48 : 2251-2257.
  • 9Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol,2002 ,39 :2026-2033.
  • 10Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the multisite stimulation in cardiomyopathy ( MUSTIC ) study. J Am Coll Cardiol,2002,40 : 111-118.

二级参考文献16

  • 1华伟,王方正,朱丽,张澍,陈柯萍,牛红霞,陈新.117例双心室再同步起搏器植入术并发症分析[J].中华心律失常学杂志,2004,8(4):252-254. 被引量:34
  • 2韩雅玲,王冬梅,臧红云,荆全民,王祖禄.心脏静脉球囊扩张及双心室同步起搏[J].中华心律失常学杂志,2005,9(1):60-61. 被引量:4
  • 3王冬梅,韩雅玲,臧红云,周微微,荆全民,王祖禄,王守力,李菲.双心室再同步起搏治疗慢性充血性心衰长期疗效及病死率分析[J].沈阳部队医药,2005,18(3):155-156. 被引量:5
  • 4Xiao HB, Gibson DG. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol, 1996,53 : 163-170.
  • 5Gras D, Mabo P, Yang T, et al. Multisite pacing as a supplemental treatment of chronic heart failure: preliminary results of the Medtronic InSync Study. PACE, 1998,21:2249-2255.
  • 6Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Eng J Med, 2001,344:873-880.
  • 7Abraham W.Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure:the Multicenter InSync Randomized Clinical Evaluation(MIRACLE).J Cardiac Failure,2000,6:369-380.
  • 8Molhoek SG,Bax JJ,Erven LV,et al.Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy.Am J Cardiol,2004,93:860-863.
  • 9Popone C,Auricchio A,Schalij M,et al.Can tansvenous left ventricular leads be used as standard treatment for heart failure patients?The European experience with the first 1000 over-the-wire lead implantation.PACE,2001,24:619.
  • 10Cleland JG,Daubert JC,Erdmann E,et al.The effect of cardiac resynchronization on morbidity and mortality in heart failure.N Engl J Med,2005,352:1539-1549.

共引文献26

同被引文献21

  • 1Holzmeister J,Leclercq C.Implantable cardioverter defibrillators and cardiac resynchronisation therapy[J],.Lancet,2011,378(9792):722-730.
  • 2Linde C,Abraham WT,Gold MR,et al.Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms[J],.J Am Coll Cardiol,2008,52(23):1834-1843.
  • 3Linde C,Abraham WT,Gold MR,et al.Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology:results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study[J],.J Am Coll Cardiol,2010,56(22):1826-1831.
  • 4Cleland JGF,Daubert JC,Erdmann E,et al.Baseline characteristics of patients recruited into the CARE-HF study.On behalf of the CAREHF study Steering Committee and Investigators[J],.Eur J Heart Fail,2005,7:205-214.
  • 5Ghio S,Freemantle N,Serio A,et al.Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (Cardiac REsynchronisation Heart Failure study)[J],.Eur J Echocardiogr,2006,7(5):373-378.
  • 6Wang J,Kurrelmeyer KM,Torre-Amione G,et al.Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy[J],.J Am Coll Cardiol,2007,49(1):88-96.
  • 7Holzmeister J,Hurlimann D,Steff J,et al.Cardiac resynchronization therapy in patients with a narrow QRS[J],.Curr Heart Fail Rep,2009,6:49-56.
  • 8Uchiyama T,Matsumoto K, Suga C, et al. QRS width does not re- flect ventricular dyssynchrony in patients with heart failure [ J ]. Artif Organs ,2005,8 : 100-103.
  • 9Lecoq G, Leclercq C, Leray E, et al. Clinical and electrocardio- graphic predictors of a positive response to cardiac resynchroniza- tion therapy in advanced heart failure [ J]. Eur Heart J,2005,26: 1094-1100.
  • 10Badano LP, Gaddi O, Peraldo C, et al. Left ventricular electrome- chanical delay in patients with heart failure and normal QRS dura- tion and in patients with right and left bundle branch block [ J ]. Europaee ,2007,9:41-47.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部